A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
The focus is typically on how changes in variables will alter profit
Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak-Szydlowska W
They claim it could enhance therapeutic outcomes alongside other peptides or treatments
Side effects and storage Most reactions are mild: injection-site soreness, warmth, or redness that fades quickly, and the transient odor effect above